The TRICURE US IDE Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 831 participants.

Also called NCT07528326

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 831 participants (planned count) (from the registry)
Sponsor
TRiCares (from the registry)
Registry
  • NCT NCT07528326
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07528326. Randomized; no masking; primary purpose treatment. Start 2026-07-08 (actual); primary completion 2031-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The TRICURE US IDE Pivotal Study
Acronym
TRICURE US IDE
Condition
Tricuspid Regurgitation (TR)
Intervention (Device)
TRiCares Topaz TTVR System
Intervention (Device)
Edwards EVOQUE TTVR System
Intervention (Device)
TRiCares Topaz TTVR System
Lead sponsor
TRiCares (class: industry)

Record details

Record id
cardio:ct-nct07528326
Content hash
6ecd1646f32aa54cd42a0bf7c4495dca1afb6745dff537d35c657330dbcb6dd5